$MLAB
MESA LABORATORIES INC /CO/ Stock $mlab

$mlab Overview Financials Valuation SEC Filings Company Website

2021 Q1 Form 10-K Financial Statement

#000143774921013801 Filed on June 01, 2021

Income Statement

Concept	2021 Q1	2020 Q4	2020 Q3
Revenue	$37.96M	$34.17M	$31.86M
YoY Change	10.98%	7.95%	24.77%
Cost Of Revenue	$13.23M	$13.52M	$10.58M
YoY Change	-15.03%	-19.78%	6.28%
Gross Profit	$24.74M	$20.65M	$21.29M
YoY Change	31.79%	39.52%	36.56%
Gross Profit Margin	65.16%	60.44%	66.81%
Selling, General & Admin	$17.68M	$17.93M	$14.40M
YoY Change	14.95%	14.38%	44.34%
% of Gross Profit	71.47%	86.8%	67.66%
Research & Development	$2.670M	$2.705M	$2.414M
YoY Change	15.58%	28.2%	163.83%
% of Gross Profit	10.79%	13.1%	11.34%
Depreciation & Amortization	$11.18M	$4.600M	$4.420M
YoY Change	103.61%	50.33%	95.58%
% of Gross Profit	45.19%	22.27%	20.77%
Operating Expenses	$20.35M	$20.63M	$16.82M
YoY Change	15.04%	14.25%	54.38%
Operating Profit	$4.386M	$22.00K	$4.470M
YoY Change	306.49%	-100.68%	-4.77%
Interest Expense	-$2.110M	$1.950M	$1.934M
YoY Change	106.86%	1.09%	38.44%
% of Operating Profit	-48.11%	8863.64%	43.27%
Other Income/Expense, Net	$2.710M	-$5.749M	-$2.086M
YoY Change	-1103.7%	215.53%	126.74%
Pretax Income	$4.890M	-$5.727M	$2.384M
YoY Change	-1353.85%	12.8%	-36.83%
Income Tax	$970.0K	-$1.185M	-$295.0K
% Of Pretax Income	19.84%		-12.37%
Net Earnings	$3.920M	-$4.542M	$2.679M
YoY Change	-333.33%	0.93%	-15.49%
Net Earnings / Revenue	10.33%	-13.29%	8.41%
Basic Earnings Per Share	$0.76	-$0.89	$0.52
Diluted Earnings Per Share	$0.74	-$0.89	$0.51
COMMON SHARES
Basic Shares Outstanding	5.132M	5.125M	5.110M
Diluted Shares Outstanding		5.125M	5.241M

Balance Sheet

Concept	2021 Q1	2020 Q4	2020 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$263.9M	$253.7M	$241.9M
YoY Change	224.2%	242.84%	-1.43%
Cash & Equivalents	$263.9M	$253.7M	$241.9M
Short-Term Investments
Other Short-Term Assets	$4.900M	$9.200M	$7.800M
YoY Change	-19.67%	9.52%	25.81%
Inventory	$11.18M	$11.97M	$11.84M
Prepaid Expenses
Receivables	$23.79M	$20.41M	$18.56M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$303.7M	$295.3M	$280.1M
YoY Change	147.37%	144.63%	3.47%
LONG-TERM ASSETS
Property, Plant & Equipment	$22.00M	$22.30M	$22.31M
YoY Change	-0.31%	-0.26%	2.66%
Goodwill	$160.8M	$165.8M	$156.4M
YoY Change	13.64%	-12.56%	133.08%
Intangibles	$111.7M	$120.8M	$116.7M
YoY Change	-6.78%	37.16%	270.17%
Long-Term Investments
YoY Change
Other Assets	$2.530M	$1.806M	$1.977M
YoY Change	2.02%	-28.13%	68.54%
Total Long-Term Assets	$297.7M	$326.4M	$308.8M
YoY Change	3.99%	7.79%	153.67%
TOTAL ASSETS
Total Short-Term Assets	$303.7M	$295.3M	$280.1M
Total Long-Term Assets	$297.7M	$326.4M	$308.8M
Total Assets	$601.5M	$621.6M	$588.9M
YoY Change	47.02%	46.8%	50.06%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$4.473M	$3.751M	$1.852M
YoY Change	31.25%	-0.77%	-20.82%
Accrued Expenses	$9.945M	$9.165M	$4.753M
YoY Change	50.57%	14.49%	1.71%
Deferred Revenue	$8.777M	$7.646M	$6.790M
YoY Change	28.81%	20.16%	70.6%
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$32.58M	$27.75M	$19.53M
YoY Change	25.28%	9.92%	16.68%
LONG-TERM LIABILITIES
Long-Term Debt	$145.7M	$144.3M	$142.9M
YoY Change	3.85%	3.81%	3.78%
Other Long-Term Liabilities	$715.0K	$686.0K	$952.0K
YoY Change	-47.35%	-50.36%	96.29%
Total Long-Term Liabilities	$715.0K	$686.0K	$952.0K
YoY Change	-47.35%	-50.36%	96.29%
TOTAL LIABILITIES
Total Short-Term Liabilities	$32.58M	$27.75M	$19.53M
Total Long-Term Liabilities	$715.0K	$686.0K	$952.0K
Total Liabilities	$195.2M	$208.8M	$196.5M
YoY Change	3.25%	10.33%	20.34%
SHAREHOLDERS EQUITY
Retained Earnings	$72.46M	$69.36M	$74.72M
YoY Change	0.14%	-6.66%	-6.17%
Common Stock	$317.7M	$314.5M	$309.9M
YoY Change	101.02%	102.12%	103.88%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$406.2M	$412.8M	$392.4M
YoY Change
Total Liabilities & Shareholders Equity	$601.5M	$621.6M	$588.9M
YoY Change	47.02%	46.8%	50.06%

Cashflow Statement

Concept	2021 Q1	2020 Q4	2020 Q3
OPERATING ACTIVITIES
Net Income	$3.920M	-$4.542M	$2.679M
YoY Change	-333.33%	0.93%	-15.49%
Depreciation, Depletion And Amortization	$11.18M	$4.600M	$4.420M
YoY Change	103.61%	50.33%	95.58%
Cash From Operating Activities	$13.52M	$10.94M	$10.54M
YoY Change	53.11%	-0.64%	63.92%
INVESTING ACTIVITIES
Capital Expenditures	-$1.040M	-$240.0K	-$490.0K
YoY Change	85.71%	-40.0%	58.06%
Acquisitions
YoY Change
Other Investing Activities	$0.00	$0.00	$0.00
YoY Change	-100.0%	-100.0%
Cash From Investing Activities	-$1.040M	-$240.0K	-$490.0K
YoY Change	89.09%	-99.87%	53.12%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-1.050M	180.0K	210.0K
YoY Change	-362.5%	-150.0%	-99.91%
NET CHANGE
Cash From Operating Activities	13.52M	10.94M	10.54M
Cash From Investing Activities	-1.040M	-240.0K	-490.0K
Cash From Financing Activities	-1.050M	180.0K	210.0K
Net Change In Cash	11.43M	10.88M	10.26M
YoY Change	31.68%	-106.35%	-95.69%
FREE CASH FLOW
Cash From Operating Activities	$13.52M	$10.94M	$10.54M
Capital Expenditures	-$1.040M	-$240.0K	-$490.0K
Free Cash Flow	$14.56M	$11.18M	$11.03M
YoY Change	55.06%	-2.02%	63.65%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2021Q2	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	5140981
CY2021Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	218000	USD
CY2020Q1	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	159000	USD
CY2021Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2020Q1	us-gaap	Common Stock No Par Value CommonStockNoParValue	0
CY2021Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2020Q1	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	25000000
CY2021Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	5140568
CY2021Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	5140568
CY2020Q1	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	4387140
CY2020Q1	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	4387140
CY2019	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.64
CY2019Q1	us-gaap	Stockholders Equity StockholdersEquity	111311000	USD
CY2020	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	5568000	USD
CY2020	mlab	Payments Of Debt Conversion Costs PaymentsOfDebtConversionCosts	8338000	USD
CY2020	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.64
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	220013000	USD
CY2021	us-gaap	Adjustments To Additional Paid In Capital Stock Issued Issuance Costs AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts	9315000	USD
CY2021	us-gaap	Common Stock Dividends Per Share Cash Paid CommonStockDividendsPerShareCashPaid	0.64
CY2021	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	4	pure
CY2021	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	0	USD
CY2021Q1	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	0	USD
CY2021	us-gaap	Number Of Reportable Segments NumberOfReportableSegments	4	pure
CY2021Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	263865000	USD
CY2020Q1	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	81380000	USD
CY2021Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	23787000	USD
CY2020Q1	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	21132000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	11178000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	14230000	USD
CY2021Q1	us-gaap	Prepaid Taxes PrepaidTaxes	4082000	USD
CY2020Q1	us-gaap	Prepaid Taxes PrepaidTaxes	4136000	USD
CY2021Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	837000	USD
CY2020Q1	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	1914000	USD
CY2021Q1	us-gaap	Assets Current AssetsCurrent	303749000	USD
CY2020Q1	us-gaap	Assets Current AssetsCurrent	122792000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21998000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22066000	USD
CY2021Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	616000	USD
CY2020Q1	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	363000	USD
CY2021Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2530000	USD
CY2020Q1	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	2480000	USD
CY2021Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	111741000	USD
CY2020Q1	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	119871000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	160841000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	141536000	USD
CY2021Q1	us-gaap	Assets Assets	601475000	USD
CY2020Q1	us-gaap	Assets Assets	409108000	USD
CY2021Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	4473000	USD
CY2020Q1	us-gaap	Accounts Payable Current AccountsPayableCurrent	3408000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9388000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8940000	USD
CY2021Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	8777000	USD
CY2020Q1	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	6814000	USD
CY2021Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	1648000	USD
CY2020Q1	us-gaap	Accrued Income Taxes Current AccruedIncomeTaxesCurrent	241000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8297000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6605000	USD
CY2021Q1	us-gaap	Liabilities Current LiabilitiesCurrent	32583000	USD
CY2020Q1	us-gaap	Liabilities Current LiabilitiesCurrent	26008000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	16275000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	21451000	USD
CY2021Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	715000	USD
CY2020Q1	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	1358000	USD
CY2021Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	145675000	USD
CY2020Q1	us-gaap	Convertible Debt Noncurrent ConvertibleDebtNoncurrent	140278000	USD
CY2021Q1	us-gaap	Liabilities Liabilities	195248000	USD
CY2020Q1	us-gaap	Liabilities Liabilities	189095000	USD
CY2021Q1	us-gaap	Common Stock Value CommonStockValue	317652000	USD
CY2020Q1	us-gaap	Common Stock Value CommonStockValue	158023000	USD
CY2021Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	72459000	USD
CY2020Q1	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	72359000	USD
CY2021Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	16116000	USD
CY2020Q1	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-10369000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	406227000	USD
CY2020Q1	us-gaap	Stockholders Equity StockholdersEquity	220013000	USD
CY2021Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	601475000	USD
CY2020Q1	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	409108000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	133937000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117687000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103135000	USD
CY2021	us-gaap	Cost Of Revenue CostOfRevenue	46923000	USD
CY2020	us-gaap	Cost Of Revenue CostOfRevenue	52325000	USD
CY2019	us-gaap	Cost Of Revenue CostOfRevenue	42219000	USD
CY2021	us-gaap	Gross Profit GrossProfit	87014000	USD
CY2020	us-gaap	Gross Profit GrossProfit	65362000	USD
CY2019	us-gaap	Gross Profit GrossProfit	60916000	USD
CY2021	us-gaap	Selling Expense SellingExpense	18480000	USD
CY2020	us-gaap	Selling Expense SellingExpense	12910000	USD
CY2019	us-gaap	Selling Expense SellingExpense	8260000	USD
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	45697000	USD
CY2020	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	37826000	USD
CY2019	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31295000	USD
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	10388000	USD
CY2020	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	6355000	USD
CY2019	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	3506000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	298000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4774000	USD
CY2021	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	91000	USD
CY2020	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	50000	USD
CY2019	us-gaap	Litigation Settlement Expense LitigationSettlementExpense	3300000	USD
CY2021	us-gaap	Operating Expenses OperatingExpenses	74656000	USD
CY2020	us-gaap	Operating Expenses OperatingExpenses	57439000	USD
CY2019	us-gaap	Operating Expenses OperatingExpenses	51135000	USD
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	12358000	USD
CY2020	us-gaap	Operating Income Loss OperatingIncomeLoss	7923000	USD
CY2019	us-gaap	Operating Income Loss OperatingIncomeLoss	9781000	USD
CY2021	us-gaap	Interest Expense InterestExpense	8024000	USD
CY2020	us-gaap	Interest Expense InterestExpense	5504000	USD
CY2019	us-gaap	Interest Expense InterestExpense	1749000	USD
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	107000	USD
CY2020	us-gaap	Investment Income Interest InvestmentIncomeInterest	960000	USD
CY2019	us-gaap	Investment Income Interest InvestmentIncomeInterest	29000	USD
CY2021	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-2138000	USD
CY2020	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	483000	USD
CY2019	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	562000	USD
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-10055000	USD
CY2020	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-4061000	USD
CY2019	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-1158000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2303000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3862000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8623000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-971000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2084000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1139000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3274000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1778000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7484000	USD
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.95
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4975000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4200000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3839000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5124000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4371000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4033000
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3274000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1778000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7484000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	26485000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8367000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2379000	USD
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	29759000	USD
CY2020	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-6589000	USD
CY2019	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	5105000	USD
CY2018Q1	us-gaap	Stockholders Equity StockholdersEquity	99361000	USD
CY2019	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	5095000	USD
CY2019	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2462000	USD
CY2019	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	4212000	USD
CY2019	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-2379000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7484000	USD
CY2020	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4945000	USD
CY2020	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	84995000	USD
CY2020	mlab	Equity Impact Of Convertible Debt With Conversion Feature EquityImpactOfConvertibleDebtWithConversionFeature	22735000	USD
CY2020	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	2722000	USD
CY2020	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	5525000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Reclassification Adjustment From Aoci Realized Upon Sale Or Liquidation Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationReclassificationAdjustmentFromAOCIRealizedUponSaleOrLiquidationNetOfTax	187000	USD
CY2020	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	-8367000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1778000	USD
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	145935000	USD
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	4426000	USD
CY2021	us-gaap	Dividends Common Stock Cash DividendsCommonStockCash	3165000	USD
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	9268000	USD
CY2021	us-gaap	Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax	26485000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3274000	USD
CY2021Q1	us-gaap	Stockholders Equity StockholdersEquity	406227000	USD
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3274000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1778000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7484000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17660000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12990000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9428000	USD
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	9268000	USD
CY2020	us-gaap	Share Based Compensation ShareBasedCompensation	5525000	USD
CY2019	us-gaap	Share Based Compensation ShareBasedCompensation	4212000	USD
CY2021	us-gaap	Asset Impairment Charges AssetImpairmentCharges	0	USD
CY2020	us-gaap	Asset Impairment Charges AssetImpairmentCharges	298000	USD
CY2019	us-gaap	Asset Impairment Charges AssetImpairmentCharges	4774000	USD
CY2021	us-gaap	Paid In Kind Interest PaidInKindInterest	5397000	USD
CY2020	us-gaap	Paid In Kind Interest PaidInKindInterest	3314000	USD
CY2019	us-gaap	Paid In Kind Interest PaidInKindInterest	0	USD
CY2021	mlab	Amortization Of Inventory Stepup Cost AmortizationOfInventoryStepupCost	-436000	USD
CY2020	mlab	Amortization Of Inventory Stepup Cost AmortizationOfInventoryStepupCost	8502000	USD
CY2019	mlab	Amortization Of Inventory Stepup Cost AmortizationOfInventoryStepupCost	0	USD
CY2019	mlab	Increase Decrease In Inventory Reserve IncreaseDecreaseInInventoryReserve	2472000	USD
CY2021	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	-161000	USD
CY2021	mlab	Increase Decrease In Inventory Reserve IncreaseDecreaseInInventoryReserve	3503000	USD
CY2020	mlab	Increase Decrease In Inventory Reserve IncreaseDecreaseInInventoryReserve	1971000	USD
CY2020	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	311000	USD
CY2019	us-gaap	Increase Decrease In Deferred Income Taxes IncreaseDecreaseInDeferredIncomeTaxes	763000	USD
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	647000	USD
CY2020	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	1665000	USD
CY2019	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1592000	USD
CY2021	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-929000	USD
CY2020	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-414000	USD
CY2019	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-2574000	USD
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-2878000	USD
CY2020	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	432000	USD
CY2019	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	2898000	USD
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	967000	USD
CY2020	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-61000	USD
CY2019	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1092000	USD
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-317000	USD
CY2020	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-2147000	USD
CY2019	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	5477000	USD
CY2021	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	1442000	USD
CY2020	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	754000	USD
CY2019	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	54000	USD
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	37073000	USD
CY2020	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	26988000	USD
CY2019	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	30554000	USD
CY2021	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	-0	USD
CY2020	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	184102000	USD
CY2019	us-gaap	Payments To Acquire Businesses Gross PaymentsToAcquireBusinessesGross	4840000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1992000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1498000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1262000	USD
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	0	USD
CY2020	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	15000	USD
CY2019	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	2222000	USD
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1992000	USD
CY2020	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-185585000	USD
CY2019	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-3880000	USD
CY2021	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	145935000	USD
CY2020	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	84995000	USD
CY2019	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	0	USD
CY2021	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2020	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	172500000	USD
CY2019	us-gaap	Proceeds From Convertible Debt ProceedsFromConvertibleDebt	0	USD
CY2021	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2020	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	0	USD
CY2019	us-gaap	Proceeds From Long Term Lines Of Credit ProceedsFromLongTermLinesOfCredit	2000000	USD
CY2021	us-gaap	Payments Of Dividends PaymentsOfDividends	3165000	USD
CY2020	us-gaap	Payments Of Dividends PaymentsOfDividends	2722000	USD
CY2019	us-gaap	Payments Of Dividends PaymentsOfDividends	2462000	USD
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	304000	USD
CY2020	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	11000	USD
CY2019	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	680000	USD
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4426000	USD
CY2020	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	4945000	USD
CY2019	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5095000	USD
CY2021	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	664000	USD
CY2020	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	5430000	USD
CY2019	us-gaap	Payments Of Debt Issuance Costs PaymentsOfDebtIssuanceCosts	-0	USD
CY2021	us-gaap	Repayments Of Debt RepaymentsOfDebt	-0	USD
CY2020	us-gaap	Repayments Of Debt RepaymentsOfDebt	23000000	USD
CY2019	us-gaap	Repayments Of Debt RepaymentsOfDebt	25625000	USD
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	146228000	USD
CY2020	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	231277000	USD
CY2019	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-21672000	USD
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	1176000	USD
CY2020	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-1485000	USD
CY2019	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	-286000	USD
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	182485000	USD
CY2020	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	71195000	USD
CY2019	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	4716000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	81380000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10185000	USD
CY2018Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	5469000	USD
CY2021Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	263865000	USD
CY2020Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	81380000	USD
CY2019Q1	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10185000	USD
CY2021	mlab	Deferred Tax Liability Related To Conversion Option Associated With Convertible Senior Notes DeferredTaxLiabilityRelatedToConversionOptionAssociatedWithConvertibleSeniorNotes	0	USD
CY2020	mlab	Deferred Tax Liability Related To Conversion Option Associated With Convertible Senior Notes DeferredTaxLiabilityRelatedToConversionOptionAssociatedWithConvertibleSeniorNotes	7359000	USD
CY2019	mlab	Deferred Tax Liability Related To Conversion Option Associated With Convertible Senior Notes DeferredTaxLiabilityRelatedToConversionOptionAssociatedWithConvertibleSeniorNotes	0	USD
CY2021	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	USD
CY2020	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	490000	USD
CY2019	us-gaap	Noncash Or Part Noncash Acquisition Value Of Liabilities Assumed1 NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1	0	USD
CY2021	us-gaap	Income Taxes Paid IncomeTaxesPaid	1367000	USD
CY2020	us-gaap	Income Taxes Paid IncomeTaxesPaid	2634000	USD
CY2019	us-gaap	Income Taxes Paid IncomeTaxesPaid	5870000	USD
CY2021	us-gaap	Interest Paid Net InterestPaidNet	2372000	USD
CY2020	us-gaap	Interest Paid Net InterestPaidNet	1627000	USD
CY2019	us-gaap	Interest Paid Net InterestPaidNet	1637000	USD
CY2021	us-gaap	Use Of Estimates UseOfEstimates	<p style="font-family: "Times New Roman", Times, serif; font-size: 10pt; margin: 0pt; text-align: left;"><b>Management Estimates</b></p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"> </p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;">The preparation of our Consolidated Financial Statements in conformity with GAAP requires us to make estimates and assumptions that affect the reported amounts of assets, liabilities, revenues and expenses and the disclosure of contingent assets and liabilities in our Consolidated Financial Statements and accompanying notes. Actual results could differ from our estimates under different assumptions or conditions.</p> <p style="font-family:'Times New Roman', Times, serif;font-size:10pt;margin:0pt;text-align:left;"><b> </b></p>
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	100000	USD
CY2020	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1000	USD
CY2019	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	13000	USD
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	0	USD
CY2020	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	184102000	USD
CY2019	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	4840000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	133937000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117687000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103135000	USD
CY2020Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	7217000	USD
CY2021	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	-4368000	USD
CY2021	mlab	Contract With Customer Liability Increase During Period Net Of Revenue Recognized ContractWithCustomerLiabilityIncreaseDuringPeriodNetOfRevenueRecognized	6145000	USD
CY2021Q1	us-gaap	Contract With Customer Liability ContractWithCustomerLiability	8994000	USD
CY2021Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	230822000	USD
CY2020Q1	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	66735000	USD
CY2021Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	5755000	USD
CY2020Q1	us-gaap	Inventory Raw Materials InventoryRawMaterials	4738000	USD
CY2021Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	426000	USD
CY2020Q1	us-gaap	Inventory Work In Process InventoryWorkInProcess	329000	USD
CY2021Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	4997000	USD
CY2020Q1	us-gaap	Inventory Finished Goods InventoryFinishedGoods	9163000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	11178000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	14230000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	38328000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	34807000	USD
CY2021Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	16330000	USD
CY2020Q1	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	12741000	USD
CY2021Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	21998000	USD
CY2020Q1	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	22066000	USD
CY2021	us-gaap	Depreciation Depreciation	2959000	USD
CY2020	us-gaap	Depreciation Depreciation	2234000	USD
CY2019	us-gaap	Depreciation Depreciation	2338000	USD
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1130000	USD
CY2020	us-gaap	Operating Lease Cost OperatingLeaseCost	987000	USD
CY2021	us-gaap	Variable Lease Cost VariableLeaseCost	272000	USD
CY2020	us-gaap	Variable Lease Cost VariableLeaseCost	68000	USD
CY2021	us-gaap	Lease Cost LeaseCost	1402000	USD
CY2020	us-gaap	Lease Cost LeaseCost	1055000	USD
CY2021Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P1Y9M18D
CY2020Q1	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y3M18D
CY2021Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.033	pure
CY2020Q1	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.039	pure
CY2021	us-gaap	Operating Lease Payments OperatingLeasePayments	1192000	USD
CY2020	us-gaap	Operating Lease Payments OperatingLeasePayments	914000	USD
CY2021	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	558000	USD
CY2020	us-gaap	Right Of Use Asset Obtained In Exchange For Operating Lease Liability RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability	1845000	USD
CY2020Q2	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	225.00
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	1055000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	580000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	96000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due Year Four LesseeOperatingLeaseLiabilityPaymentsDueYearFour	11000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	1742000	USD
CY2021Q1	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	42000	USD
CY2019Q1	us-gaap	Goodwill Goodwill	66377000	USD
CY2020	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	-2653000	USD
CY2020	us-gaap	Goodwill Acquired During Period GoodwillAcquiredDuringPeriod	78070000	USD
CY2020	us-gaap	Goodwill Impairment Loss GoodwillImpairmentLoss	258000	USD
CY2020Q1	us-gaap	Goodwill Goodwill	141536000	USD
CY2021	us-gaap	Goodwill Foreign Currency Translation Gain Loss GoodwillForeignCurrencyTranslationGainLoss	11337000	USD
CY2021	us-gaap	Goodwill Purchase Accounting Adjustments GoodwillPurchaseAccountingAdjustments	7968000	USD
CY2021Q1	us-gaap	Goodwill Goodwill	160841000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	176866000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	65125000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	111741000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Gross FiniteLivedIntangibleAssetsGross	169123000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Accumulated Amortization FiniteLivedIntangibleAssetsAccumulatedAmortization	49252000	USD
CY2020Q1	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	119871000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	14930000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	14721000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	14206000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	12612000	USD
CY2021Q1	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	11824000	USD
CY2021	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	14513000	USD
CY2020	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	10637000	USD
CY2019	us-gaap	Amortization Of Intangible Assets AmortizationOfIntangibleAssets	7090000	USD
CY2005Q4	us-gaap	Stock Repurchase Program Number Of Shares Authorized To Be Repurchased StockRepurchaseProgramNumberOfSharesAuthorizedToBeRepurchased	300000
CY2021	us-gaap	Stock Repurchased During Period Value StockRepurchasedDuringPeriodValue	0	USD
CY2021Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	3504000	USD
CY2020Q1	us-gaap	Accrued Bonuses Current AccruedBonusesCurrent	4069000	USD
CY2021Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	3562000	USD
CY2020Q1	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	2485000	USD
CY2021Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2043000	USD
CY2020Q1	us-gaap	Accrued Payroll Taxes Current AccruedPayrollTaxesCurrent	2228000	USD
CY2021Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	279000	USD
CY2020Q1	us-gaap	Other Employee Related Liabilities Current OtherEmployeeRelatedLiabilitiesCurrent	158000	USD
CY2021Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	9388000	USD
CY2020Q1	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	8940000	USD
CY2021Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	4749000	USD
CY2020Q1	us-gaap	Taxes Payable Current TaxesPayableCurrent	3555000	USD
CY2021Q1	us-gaap	Interest Payable Current InterestPayableCurrent	303000	USD
CY2020Q1	us-gaap	Interest Payable Current InterestPayableCurrent	296000	USD
CY2021Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	473000	USD
CY2020Q1	us-gaap	Accrued Professional Fees Current AccruedProfessionalFeesCurrent	857000	USD
CY2021Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	235000	USD
CY2020Q1	us-gaap	Business Combination Contingent Consideration Liability Current BusinessCombinationContingentConsiderationLiabilityCurrent	504000	USD
CY2021Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1514000	USD
CY2020Q1	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	298000	USD
CY2021Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	8297000	USD
CY2020Q1	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	6605000	USD
	us-gaap	Stock Repurchased During Period Shares StockRepurchasedDuringPeriodShares	162486
CY2020Q2	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	600000
CY2020Q2	mlab	Sale Of Stock Underwriter Options Shares SaleOfStockUnderwriterOptionsShares	90000
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P3Y1M6D
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	33927000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	36000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	226.72
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod	13000
CY2020Q2	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	145935000	USD
CY2019Q3	us-gaap	Stock Issued During Period Shares New Issues StockIssuedDuringPeriodSharesNewIssues	431250
CY2019Q3	mlab	Sale Of Stock Underwriter Options Shares SaleOfStockUnderwriterOptionsShares	56250
CY2019Q3	us-gaap	Shares Issued Price Per Share SharesIssuedPricePerShare	210.00
CY2019Q3	us-gaap	Proceeds From Issuance Of Common Stock ProceedsFromIssuanceOfCommonStock	84995000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	9268000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	5525000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	4212000	USD
CY2021	mlab	Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense	-1816000	USD
CY2020	mlab	Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense	-1576000	USD
CY2019	mlab	Employee Service Sharebased Compensation Tax Expense Benefit From Compensation Expense EmployeeServiceSharebasedCompensationTaxExpenseBenefitFromCompensationExpense	-2370000	USD
CY2021	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	7452000	USD
CY2020	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	3949000	USD
CY2019	us-gaap	Allocated Share Based Compensation Expense Net Of Tax AllocatedShareBasedCompensationExpenseNetOfTax	1842000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0027	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0180	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0263	pure
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y10M9D
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y3M29D
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P5Y
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0010	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0013	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0.0045	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3883	pure
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3652	pure
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.3596	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	67.66
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	66.02
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	54.02
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	286000
CY2021	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	56000
CY2021	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	84.40
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice	115.23
CY2020Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	107.72
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	253000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	129.55
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P2Y8M12D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	28856000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	121000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	102.31
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y
CY2021Q1	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	17155000	USD
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	246000
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableWeightedAverageExercisePrice	132.59
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P2Y8M12D
CY2021Q1	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	28847000	USD
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9559000	USD
CY2020	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	9574000	USD
CY2019	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	10895000	USD
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2005000	USD
CY2020	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	1912000	USD
CY2019	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	2400000	USD
CY2020	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	206.35
CY2019	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	144.96
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3274000	USD
CY2020	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1778000	USD
CY2019	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	7484000	USD
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4975000
CY2020	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	4200000
CY2019	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	3839000
CY2021	mlab	Incremental Common Shares Attributable To Dilutive Effect Of Stock Options IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions	125000
CY2020	mlab	Incremental Common Shares Attributable To Dilutive Effect Of Stock Options IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions	159000
CY2019	mlab	Incremental Common Shares Attributable To Dilutive Effect Of Stock Options IncrementalCommonSharesAttributableToDilutiveEffectOfStockOptions	186000
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	5124000
CY2020	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4371000
CY2019	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	4033000
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.66
CY2020	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.42
CY2019	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.95
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.64
CY2020	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.41
CY2019	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.86
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	666000
CY2020	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	429000
CY2019	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	11000
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	935000	USD
CY2020	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	661000	USD
CY2019	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	663000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	6297000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	16059000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	12133000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3994000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-12197000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	-3510000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	2303000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	3862000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments	8623000	USD
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1500000	USD
CY2020	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	2348000	USD
CY2019	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	1831000	USD
CY2021	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	628000	USD
CY2020	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	814000	USD
CY2019	us-gaap	Current State And Local Tax Expense Benefit CurrentStateAndLocalTaxExpenseBenefit	449000	USD
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	404000	USD
CY2020	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	993000	USD
CY2019	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	1166000	USD
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	2532000	USD
CY2020	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	4155000	USD
CY2019	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	3446000	USD
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-2410000	USD
CY2020	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	60000	USD
CY2019	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-741000	USD
CY2021	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-619000	USD
CY2020	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	599000	USD
CY2019	us-gaap	Deferred State And Local Income Tax Expense Benefit DeferredStateAndLocalIncomeTaxExpenseBenefit	-106000	USD
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-474000	USD
CY2020	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-2730000	USD
CY2019	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1460000	USD
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-3503000	USD
CY2020	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2071000	USD
CY2019	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2307000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-971000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2084000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1139000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8990000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	8874000	USD
CY2020	mlab	Effective Income Tax Rate Reconciliation Limitation For162m Amount EffectiveIncomeTaxRateReconciliationLimitationFor162mAmount	1112000	USD
CY2019	mlab	Effective Income Tax Rate Reconciliation Limitation For162m Amount EffectiveIncomeTaxRateReconciliationLimitationFor162mAmount	766000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	2099000	USD
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	810000	USD
CY2020	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	657000	USD
CY2019	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	0	USD
CY2021	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	-176000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1265000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	838000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Inventory DeferredTaxAssetsInventory	504000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	13801000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	11461000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	23029000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Goodwill And Intangible Assets DeferredTaxLiabilitiesGoodwillAndIntangibleAssets	24825000	USD
CY2021Q1	mlab	Deferred Tax Liabilities Deferred Expense Debt DeferredTaxLiabilitiesDeferredExpenseDebt	4723000	USD
CY2020Q1	mlab	Deferred Tax Liabilities Deferred Expense Debt DeferredTaxLiabilitiesDeferredExpenseDebt	5982000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1275000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Property Plant And Equipment DeferredTaxLiabilitiesPropertyPlantAndEquipment	1286000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	29000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	1471000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	105000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	209000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefits	208000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	169000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Other DeferredTaxAssetsTaxCreditCarryforwardsOther	47000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	25000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	458000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities Other DeferredTaxLiabilitiesOther	65000	USD
CY2021Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	29056000	USD
CY2020Q1	us-gaap	Deferred Income Tax Liabilities DeferredIncomeTaxLiabilities	32158000	USD
CY2021Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	404000	USD
CY2020Q1	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	391000	USD
CY2021Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	15659000	USD
CY2020Q1	us-gaap	Deferred Tax Liabilities DeferredTaxLiabilities	21088000	USD
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	483000	USD
CY2020	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	811000	USD
CY2019	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	1811000	USD
CY2021	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	-221000	USD
CY2020	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	1122000	USD
CY2019	us-gaap	Income Tax Reconciliation State And Local Income Taxes IncomeTaxReconciliationStateAndLocalIncomeTaxes	208000	USD
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1816000	USD
CY2020	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-1576000	USD
CY2019	us-gaap	Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost	-2034000	USD
CY2021	mlab	Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Deduction Amount EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionAmount	999000	USD
CY2020	mlab	Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Deduction Amount EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionAmount	-0	USD
CY2019	mlab	Effective Income Tax Rate Reconciliation Foreign Derived Intangible Income Deduction Amount EffectiveIncomeTaxRateReconciliationForeignDerivedIntangibleIncomeDeductionAmount	-0	USD
CY2021	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	165000	USD
CY2020	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	191000	USD
CY2019	us-gaap	Income Tax Reconciliation Tax Credits Research IncomeTaxReconciliationTaxCreditsResearch	158000	USD
CY2021	mlab	Effective Income Tax Rate Reconciliation Limitation For162m Amount EffectiveIncomeTaxRateReconciliationLimitationFor162mAmount	1113000	USD
CY2021	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	629000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	1027000	USD
CY2020	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	149000	USD
CY2019	us-gaap	Income Tax Reconciliation Other Reconciling Items IncomeTaxReconciliationOtherReconcilingItems	546000	USD
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-971000	USD
CY2020	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	2084000	USD
CY2019	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	1139000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	0	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	19000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	40000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	653000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1361000	USD
CY2018Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	827000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions	-0	USD
CY2021	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	40000	USD
CY2020	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	319000	USD
CY2019	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	534000	USD
CY2021Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	64000	USD
CY2020Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	653000	USD
CY2019Q1	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	1361000	USD
CY2021	mlab	Effective Income Tax Rate Reconciliation Foreignderived Intangible Income Deduction Based On Updated Treasury Regulations Amount EffectiveIncomeTaxRateReconciliationForeignderivedIntangibleIncomeDeductionBasedOnUpdatedTreasuryRegulationsAmount	630000	USD
CY2021	mlab	Effective Income Tax Rate Reconciliation Foreignderived Intangible Income Deduction Percentage EffectiveIncomeTaxRateReconciliationForeignderivedIntangibleIncomeDeductionPercentage	0.060	pure
CY2021Q1	us-gaap	Unrecognized Tax Benefits That Would Impact Effective Tax Rate UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate	64000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	133937000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117687000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103135000	USD
CY2021	us-gaap	Gross Profit GrossProfit	87014000	USD
CY2020	us-gaap	Gross Profit GrossProfit	65362000	USD
CY2019	us-gaap	Gross Profit GrossProfit	60916000	USD
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	2303000	USD
CY2020	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	3862000	USD
CY2019	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	8623000	USD
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	17660000	USD
CY2020	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	12990000	USD
CY2019	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9428000	USD
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1992000	USD
CY2020	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1498000	USD
CY2019	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1262000	USD
CY2021Q1	us-gaap	Inventory Net InventoryNet	11178000	USD
CY2020Q1	us-gaap	Inventory Net InventoryNet	14230000	USD
CY2021Q1	us-gaap	Noncurrent Assets NoncurrentAssets	24528000	USD
CY2020Q1	us-gaap	Noncurrent Assets NoncurrentAssets	24546000	USD
CY2021	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	133937000	USD
CY2020	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	117687000	USD
CY2019	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	103135000	USD
CY2020Q2	us-gaap	Revenues Revenues	29941000	USD
CY2020Q3	us-gaap	Revenues Revenues	31860000	USD
CY2020Q4	us-gaap	Revenues Revenues	34172000	USD
CY2021Q1	us-gaap	Revenues Revenues	37964000	USD
CY2020Q2	us-gaap	Gross Profit GrossProfit	20340000	USD
CY2020Q3	us-gaap	Gross Profit GrossProfit	21285000	USD
CY2020Q4	us-gaap	Gross Profit GrossProfit	20653000	USD
CY2021Q1	us-gaap	Gross Profit GrossProfit	24736000	USD
CY2020Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4542000	USD
CY2021Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3920000	USD
CY2020Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.27
CY2020Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	1217000	USD
CY2020Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	2679000	USD
CY2020Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.52
CY2020Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.89
CY2021Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2020Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.26
CY2020Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.51
CY2020Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.89
CY2021Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.74
CY2019Q2	us-gaap	Revenues Revenues	26288000	USD
CY2019Q3	us-gaap	Revenues Revenues	25536000	USD
CY2019Q4	us-gaap	Revenues Revenues	31655000	USD
CY2020Q1	us-gaap	Revenues Revenues	34208000	USD
CY2019Q2	us-gaap	Gross Profit GrossProfit	16204000	USD
CY2019Q3	us-gaap	Gross Profit GrossProfit	15586000	USD
CY2019Q4	us-gaap	Gross Profit GrossProfit	14803000	USD
CY2020Q1	us-gaap	Gross Profit GrossProfit	18769000	USD
CY2019Q2	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	4662000	USD
CY2019Q3	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	3172000	USD
CY2019Q4	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-4504000	USD
CY2020Q1	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-1552000	USD
CY2019Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.20
CY2019Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.76
CY2019Q4	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-1.03
CY2020Q1	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.37
CY2019Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.14
CY2019Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.73
CY2019Q4	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-1.03
CY2020Q1	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.37

Files In Submission

Name	View Source	Status
0001437749-21-013801-index-headers.html	Edgar Link	pending
0001437749-21-013801-index.html	Edgar Link	pending
0001437749-21-013801.txt	Edgar Link	pending
0001437749-21-013801-xbrl.zip	Edgar Link	pending
ex_224511.htm	Edgar Link	pending
ex_224512.htm	Edgar Link	pending
ex_224513.htm	Edgar Link	pending
ex_224515.htm	Edgar Link	pending
ex_224516.htm	Edgar Link	pending
ex_224517.htm	Edgar Link	pending
ex_224518.htm	Edgar Link	pending
ex_251804.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
mlab-20210331.xsd	Edgar Link	pending
mlab-20210331_cal.xml	Edgar Link	unprocessable
mlab-20210331_def.xml	Edgar Link	unprocessable
mlab-20210331_lab.xml	Edgar Link	unprocessable
mlab-20210331_pre.xml	Edgar Link	unprocessable
mlab20210331_10k.htm	Edgar Link	pending
mlab20210331_10k_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R77.htm	Edgar Link	pending
R78.htm	Edgar Link	pending
R79.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R80.htm	Edgar Link	pending
R81.htm	Edgar Link	pending
R82.htm	Edgar Link	pending
R83.htm	Edgar Link	pending
R84.htm	Edgar Link	pending
R85.htm	Edgar Link	pending
R86.htm	Edgar Link	pending
R87.htm	Edgar Link	pending
R88.htm	Edgar Link	pending
R89.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
R90.htm	Edgar Link	pending
R91.htm	Edgar Link	pending
R92.htm	Edgar Link	pending
report.css	Edgar Link	pending
shareperformance_2.jpg	Edgar Link	pending
Show.js	Edgar Link	pending

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$MLAB
MESA LABORATORIES INC /CO/ Stock $mlab

2021 Q1 Form 10-K Financial Statement

#000143774921013801 Filed on June 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLAB MESA LABORATORIES INC /CO/ Stock $mlab

2021 Q1 Form 10-K Financial Statement

#000143774921013801 Filed on June 01, 2021

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$MLAB
MESA LABORATORIES INC /CO/ Stock $mlab